Clinical Trials
38 trialsTesting the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines
National Cancer Institute (NCI)
MTTRIHPW
Obstetrics & Gynecology Hospital of Fudan University
Histopathological Changes in Mycosis Fungoides
Bezmialem Vakif University
Skin Tumor Biomarkers by Mass Spectrometry Imaging
Bispebjerg Hospital
Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma
Poitiers University Hospital
OpACIN-neo
The Netherlands Cancer Institute
OSIRIS
The Netherlands Cancer Institute
Fusobacterium Nucleatum at Colorectal Cancer Sites
Malmö University
PIONeeR
Assistance Publique Hopitaux De Marseille
Melamoma4p
Regina Elena Cancer Institute
Bitter Taste Receptors in Oropharynx Cancer
Technische Universität Dresden
[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors
Karolinska University Hospital
MITOSKIN
University Hospital, Bordeaux
ProstaPilot
Masaryk Memorial Cancer Institute
Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.
Istituto Clinico Humanitas
IMPACNEO
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
OPT-1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms
Samsung Medison
Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients
Northwestern University
TCR
The Netherlands Cancer Institute
SISYPHUS
Centro Hospitalar Lisboa Ocidental
IMPemBra
The Netherlands Cancer Institute
Cholangioscopy
Asian Institute of Gastroenterology, India
PaMP
University of Sao Paulo
AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer
National Cancer Institute (NCI)
Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
National Cancer Institute (NCI)
Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions
National Cancer Institute (NCI)
Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
National Cancer Institute (NCI)
Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome
National Cancer Institute (NCI)
Erlotinib in Treating Patients With Barrett Esophagus
National Cancer Institute (NCI)
High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma
National Cancer Institute (NCI)
fnab
SB Istanbul Education and Research Hospital
Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
National Cancer Institute (NCI)
Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma
National Cancer Institute (NCI)
Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
National Cancer Institute (NCI)
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
National Cancer Institute (NCI)
Biopsy Incisional With Trepan in Periocular Lesions
University of Sao Paulo